美股市场个股详情
GERN 杰龙
- 4.220
- -0.030-0.71%
收盘价 11/05 16:00 (美东)
- 4.220
- 0.0000.00%
盘后 20:01 (美东)
25.44亿总市值-12057市盈率TTM
4.320最高价4.120最低价602.91万股成交量4.300今开4.250昨收2548.30万成交额1.09%换手率亏损市盈率(静)6.03亿总股本5.34052周最高8.29市净率23.46亿流通值1.64052周最低--股息TTM5.56亿流通股75.875历史最高--股息率TTM4.71%振幅0.750历史最低4.226平均价1股每手
关于杰龙公司
杰龙公司是一家临床阶段生物制药公司，专注于研究和开发癌症治疗药物。公司的在研药物 Imelstat 正在接受测试，用于治疗骨髓增生异常综合征，一种血液疾病，和骨髓纤维化，一种影响骨髓的罕见血癌。公司通过合作协议，里程碑，版税和许可安排获得收入。杰龙拥有该药物的各种权利。该公司的业务只有一个分部，即开发肿瘤治疗产品。
公司介绍
公司代码GERN
公司名称杰龙
上市日期1996/07/30
发行价格8.00
成立日期1990
CEODr. John A. Scarlett,M.D.
所属市场纳斯达克
员工数量141
年结日12-31
公司地址919 East Hillsdale Boulevard,Suite 250
城市Foster City
省份加利福尼亚州
国家美国
邮编94404
电话1-650-473-7700
董事高管
- 姓名
- 职务
- 年薪
- Dr. John A. Scarlett,M.D.
- Chairman of the Board, Chief Executive Officer and President
- 492.41万
- Anil Kapur
- Executive Vice President, Corporate Strategy and Chief Commercial Officer
- --
- Dr. Faye Feller
- Executive Vice President and Chief Medical Officer
- --
- Edward E. Koval
- Executive Vice President and Chief Business Officer
- --
- Shannon T. Odam
- Senior Vice President and Chief People Officer
- --
- Melissa A. Kelly Behrs
- Executive Vice President, Business Operations and Chief Alliance Officer
- --
- Dr. Andrew J. Grethlein,PhD
- Executive Vice President and Chief Operating Officer
- 241.51万
- Michelle Robertson
- Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
- 246.97万
- Scott A. Samuels
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- 360.87万
- Elizabeth G. O’Farrell
- Lead Independent Director
- 37.55万
- Dawn Carter Bir
- Independent Director
- 34.31万
- Dr. Susan M. Molineaux, PhD
- Independent Director
- 34.59万
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Independent Director
- 35.09万
- Dr. V. Bryan Lawlis, PhD
- Independent Director
- 36.09万
- Dr. Gaurav Aggarwal, M.D.
- Independent Director
- 29.08万
- John F. McDonald
- Independent Director
- 34.84万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据